News
Avicenna Alliance Submits MDR Revision Proposals to the European Commission
The Avicenna Alliance is pleased to announce that, in a letter sent to the European Commissioner for Health and Animal Welfare, Olivér Várhelyi, we have formally submitted our proposals for the revision of the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) to the European Commission.
Advancing In Silico Medicine: Strengthening Dialogue with EU Policymakers
On February 17, our President & Secretary General Thierry Marchal, alongside Nayara Maldonado Solís from RPP, had the opportunity to meet with the team of MEP Kulja, MD, to discuss the creation of an MEP In Silico Coalition. This initiative would establish a regular dialogue between in silico experts from the Avicenna Alliance and the VPH Institute, and MEPs committed to new technologies in healthcare.
Welcome to René Bombien, New Co-Chair of the Clinical Deployment Task Force
The Avicenna Alliance is pleased to welcome René Bombien as the new Co-Chair of the Clinical Deployment Task Force.
In Silico Medicine: A New Scientific Discipline Emerges in Greece
On December 21, 2024, Research Professor Georgios S. Stamatakos, a great pioneer of in silico oncology, delivered a lecture in Sparta, Greece, exploring the emergence, evolution, and clinical potential of in silico medicine.
Introducing the plain language in silico medicine glossary
As in silico medicine continues to advance, new concepts and terms emerge rapidly—often before widespread consensus is established. To make this transformative field more accessible to all the stakeholders including the patients, we are pleased to present the “Plain language in silico medicine glossary”, now published on Zenodo.
Happy New Year, 2025, the Millennium Year
Dear Avicenna Alliance members, As we welcome the new year, we hope you had a joyful holiday season filled with moments of relaxation and happiness with your loved ones.
